MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia. (Q53305630)
Jump to navigation
Jump to search
scientific article published on 17 August 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia. |
scientific article published on 17 August 2010 |
Statements
MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia (English)
Beatriz Pelacho
Gloria Abizanda
Maialen Uriz
Manu Beerens
Margarita Ecay
Inés Prieto
Maitane Perez-Ilzarbe
17 August 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference